Angiogenic Factors Are Associated with Development of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

被引:0
|
作者
聂第敏 [1 ]
吴秋玲 [1 ]
朱夏夏 [1 ]
张然 [1 ]
郑鹏 [1 ]
方俊 [1 ]
游泳 [1 ]
仲照东 [1 ]
夏凌辉 [1 ]
洪梅 [1 ]
机构
[1] Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
基金
中国国家自然科学基金;
关键词
allogeneic hematopoietic stem cell transplantation; acute graft-versus-host disease; angiogenic factors; endothelial damage;
D O I
暂无
中图分类号
R457.7 [骨髓移植];
学科分类号
100215 ;
摘要
Acute graft-versus-host disease(a GVHD) is a serious complication after allogeneic hematopoietic stem cell transplantation(allo-HSCT). However,the mechanisms of a GVHD are not well understood. We aim to investigate the roles of the three angiogenic factors: angiopoietin-1(Ang-1),Ang-2 and vascular endothelial growth factor(VEGF) in the development of a GVHD. Twenty-one patients who underwent allo-HSCT were included in our study. The dynamic changes of Ang-1,Ang-2 and VEGF were monitored in patients before and after allo-HSCT. In vitro,endothelial cells(ECs) were treated with TNF-α in the presence or absence of Ang-1,and then the Ang-2 level in the cell culture medium and the tubule formation by ECs were evaluated. After allo-HSCT,Ang-1,Ang-2 and VEGF all exhibited significant variation,suggesting these factors might be involved in the endothelial damage in transplantation. Patients with a GVHD had lower Ang-1 level at day 7 but higher Ang-2 level at day 21 than those without a GVHD,implying that Ang-1 may play a protective role in early phase yet Ang-2 is a promotion factor to a GVHD. In vitro,TNF-α promoted the release of Ang-2 by ECs and impaired tubule formation of ECs,which were both weakened by Ang-1,suggesting that Ang-1 may play a protective role in a GVHD by influencing the secretion of Ang-2,consistent with our in vivo tests. It is concluded that monitoring changes of these factors following allo-HSCT might help to identify patients at a high risk for a GVHD.
引用
收藏
页码:694 / 699
页数:6
相关论文
共 50 条
  • [31] Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Xiaohui Zhang
    Yi Zhou
    Lanping Xu
    Wei Han
    Huan Chen
    Yuhong Chen
    Haixia Fu
    Shiyuan Zhou
    Jingzhong Zhao
    Qianming Wang
    Feier Feng
    Xiaolu Zhu
    Kaiyan Liu
    Xiaojun Huang
    Annals of Hematology, 2015, 94 : 837 - 845
  • [32] Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Zhang, Xiaohui
    Zhou, Yi
    Xu, Lanping
    Han, Wei
    Chen, Huan
    Chen, Yuhong
    Fu, Haixia
    Zhou, Shiyuan
    Zhao, Jingzhong
    Wang, Qianming
    Feng, Feier
    Zhu, Xiaolu
    Liu, Kaiyan
    Huang, Xiaojun
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 837 - 845
  • [33] Effect of Early Posttransplantation Tacrolimus Concentration on the Development of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors
    Mori, Takehiko
    Kato, Jun
    Shimizu, Takayuki
    Aisa, Yoshinobu
    Nakazato, Tomonori
    Yamane, Akiko
    Ono, Yukako
    Kunimoto, Hiroyoshi
    Okamoto, Shinichiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : 229 - 234
  • [34] Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
    Pidala, Joseph
    Kim, Jongphil
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (07) : 881 - 885
  • [35] Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
    Tilmont, Remi
    Yakoub-Agha, Ibrahim
    Ramdane, Nassima
    Srour, Micha
    Coiteux, Valerie
    Magro, Leonardo
    Odou, Pascal
    Simon, Nicolas
    Beauvais, David
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (09) : 1007 - 1015
  • [36] Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation
    Su, Long
    Wei, Zhi-Feng
    Pi, Chen-Chen
    Qin, Tian-Xue
    Song, Fei
    Zhang, Yun-Wei
    Gao, Su-Jun
    PHYTOMEDICINE, 2024, 132
  • [37] Correlation of Tc17 cells at early stages after allogeneic hematopoietic stem cell transplantation with acute graft-versus-host disease
    Wang, Ling
    Zhao, Peng
    Song, Lingling
    Yan, Fahong
    Shi, Chunlei
    Li, Ying
    Han, Mingzhe
    Lan, Ketao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 41 : 122 - 126
  • [38] Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
    Balassa, Katalin
    Krahling, Tunde
    Remenyi, Peter
    Batai, Arpad
    Bors, Andras
    Kiss, Katalin Piroska
    Torbagyi, Eva
    Gopcsa, Laszlo
    Lengyel, Lilla
    Barta, Aniko
    Varga, Gergely
    Tordai, Attila
    Masszi, Tamas
    Andrikovics, Hajnalka
    LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 391 - 398
  • [39] De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
    Cho, Yul Hee
    Kang, Seok Hui
    Kim, Yaeni
    Lee, Myung Hyun
    An, Gun Hee
    Chung, Byung Ha
    Choi, Bum Soon
    Yang, Chul Woo
    Kim, Yong-Soo
    Choi, Yeong Jin
    Park, Cheol Whee
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (03) : 121 - 126
  • [40] Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Reddy, V
    Winer, AG
    Eksioglu, E
    Meier-Kriesche, HU
    Schold, JD
    Wingard, JR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) : 1014 - 1021